Skip to content
★ Sign in to follow
SL

Simpson Limited

Chairman
Related company / holding
RTW Biotech Opportunities Ltd
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€231k
▼ Sales (0 ops.)
—

Latest filing published 03 Jun 2025 for RTW Biotech Opportunities Ltd, €20k.

Filing timeline

BuySale
Simpson Limited

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5
Positive at T+90
67%
Median T+90
+19.5%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Simpson Limited: trading record in brief

Simpson Limited discloses dealings in RTW Biotech Opportunities Ltd to RNS (LSE). The record holds 5 filings, for trades running from 24 April 2020 to 2 June 2025.

Purchases make up the whole of the open-market record (5 purchases, €231k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2025 to date brings 2 purchases and no sales.

The median purchase comes to €44k. Ninety days after publication, 3 purchases show a median change of +19.5%, with the price up in 67% of them. This is a record of the past, not a forecast.

The newest entry dates from 3 June 2025: an open-market purchase of €20k, in RTW Biotech Opportunities Ltd. Filings reach the RNS (LSE) feed a median of 3 days after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Simpson Limited

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    Related company / holdingExecutivesRTW Biotech Opportunities Ltd
    17,233 GBP9RNS
    15,000 shares@ £1.148923.9% of flowLondon Stock ExchangeISIN GG00BKTRRM22RNS:5679768
    Canonical exit: 31 Aug 2025 (T+90)
  • ▲
    Related company / holdingExecutivesRTW Biotech Opportunities Ltd
    53,960 GBP15RNS
    40,000 shares@ £1.34976.1% of flowLondon Stock ExchangeISIN GG00BKTRRM22RNS:5539935
    Canonical exit: 15 May 2025 (T+90)
  • ▲
    Related company / holdingExecutivesRTW Biotech Opportunities Ltd
    47,500 USD0FCA-NSM
    25,000 shares@ US$1.90London Stock ExchangeISIN GG00BKTRRM22FCA-NSM:4083262
    Canonical exit: 14 Nov 2021 (T+90)
  • ▲
    Related company / holdingExecutivesRTW Biotech Opportunities Ltd
    53,000 USD0FCA-NSM
    25,000 shares@ US$2.12London Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3855872
    Canonical exit: 25 Apr 2021 (T+90)
  • ▲
    Related company / holdingExecutivesRTW Biotech Opportunities Ltd
    66,405 USD0FCA-NSM
    57,000 shares@ US$1.165London Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3578483-0
    Canonical exit: 23 Jul 2020 (T+90)

5 of 5 declarations